Anika Therapeutics | ANIK - Acreedores Comerciales





Acreedores Comerciales Cambio Fecha
Abbott USD 4.68B 439M 2026-03
Agenus USD 58.98M 12.1M 2026-06
Agios Pharmaceuticals USD 16.34M 2.6M 2026-06
Anika Therapeutics USD 6.24M 103K 2026-06
Arrowhead Research USD 27.78M 2.97M 2026-06
Enanta Pharmaceuticals USD 1.88M 63K 2025-12
Halozyme Therapeutics USD 23.61M 9.51M 2026-06
Heron Therapeutics USD 11.64M 2.67M 2026-06
Insmed USD 74.55M 1.18M 2026-06
Integra LifeSciences USD 82.64M 5.31M 2026-06
Intrexon USD 4.85M 3.12M 2024-06
J&J USD 9.22B 1.24B 2026-06
Karyopharm Therapeutics USD 4.28M 276K 2026-03
Ligand Pharmaceuticals USD 9.4M 27.7M 2026-06
MacroGenics USD 3.44M 845K 2026-06
Merit Medical Systems USD 70.74M 2.88M 2026-06
Rigel Pharmaceuticals USD 3.85M 3.44M 2025-09
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sanofi EUR 23.6B 888M 2026-06
Smith & Nephew USD 1.62B 426M 2026-06
Stryker USD 1.59B 207M 2026-03
Veracyte USD 8.02M 1.12M 2026-06
Xencor USD 12.65M 4.73M 2026-06
Zimmer Biomet Holdings USD 352.4M 8.8M 2026-06